De-Kuan Chang
1Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA
2Department of Medicine, Harvard Medical School, 25 Shattuck Street, Boston, MA 02215, USA
Received date: April 23, 2016; Accepted date: April 24, 2016; Published date: April 27, 2016
Citation: Chang DK. Editorial Welcome Message. Reproductiv Immunol Open Acc. 2016, 1:11. doi: 10.4172/2476-1974.100011
Copyright: © 2016 Chang DK. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Cancers can occur in the reproductive system, such as cervix, uterus, and ovaries. These disorders affect millions of people and have no curative treatment. Recent reports revealed that the survival rates for gynecologic cancer patients are associated with immunity. In the effort of antitumor drug discovery, immunotherapies for cancer treatment have showed the potential therapeutic index and benefits to generate a greater immune response against the cancer.
Cancers can occur in the reproductive system, such as cervix, uterus, and ovaries. These disorders affect millions of people and have no curative treatment. Recent reports revealed that the survival rates for gynecologic cancer patients are associated with immunity. In the effort of antitumor drug discovery, immunotherapies for cancer treatment have showed the potential therapeutic index and benefits to generate a greater immune response against the cancer.
Reproductive Immunology: Open Access combines the viewpoints of neoplasms of the reproductive track and immunological interaction across these components.
Therefore, we are delighted to invite investigators in this field for submission of any kind of articles in our journal.